ISO IDMP has been around since 2012, when the standards were initially published, and since November 2012 the implementing regulation 520/2012 has been in place. Now, four years later, the deadline of July 1st, 2016, is closing in and information on how and what to implement is still scarce due to outstanding implementation guidelines from ISO, and hence no implementation guidelines from EMA. Rune Bergendorff from NNIT looks into the ISO IDMP short timelines and limited information, and then he answers the question, how do you solve the challenges and prioritise your efforts?
https://international-pharma.com/wp-content/uploads/2015/06/ISO-IDMP…PDF.pdf
Current Edition
Current Edition
Subsection - CDMO
Examining how innovative technologies, integrated manufacturing approaches and AI are shaping manufacturing.
Continue readingSubsection - Injectables
Exploring advances in injectable drug delivery and sterile manufacturing, designed to improve patient-centric delivery.
Continue readingSubsection - Neurodegenerative Diseases
Exploring emerging approaches to neurodegenerative disease research and treatment.
Continue readingSubsection - Nasal & Pulmonary
Highlighting how advances in nasal and pulmonary drug delivery, formulation, devices and analytics are enabling more complex therapies.
Continue reading
ISO IDMP Short Timelines and Limited Information: How Do You Solve the Challenges and Prioritise your Efforts? – Rune Berggendorf, NNIT
